Hispanics/Latinos patients with early-onset CRC had higher rates of TP53 (71.4% versus 68.1%, p = 1), APC (66.7 versus 52.2%, p = 0.5), and KRAS (38.1% versus 37.7%, p < 0.7) compared to early onset NHW patients, but this was not statistically significant (Table 4). Here, TP53 is linked to colorectal carcinoma.